AMRIA PNEC 2026: Table 1
Predicted no-effect concentrations (PNECs) for antibiotics, used to assess environmental risk from manufacturing.
AMRIA PNEC 2026: Supplementary Table 2
Supplementary table to the PNEC list.
AMR Industry Alliance Updates Responsible Manufacturing Standard, Further Aligning with WHO Guidance
Geneva, Switzerland, 13 May 2025 — The AMR Industry Alliance today announced it has updated its Antibiotic Manufacturing Standard, further aligning the framework with the World Health Organization’s 2024 Guidance for Responsible and Sustainable Manufacturing of Antibiotics. The Standard provides clear guidance to manufacturers in the global antibiotic supply chain to ensure that their […]
Antibiotic Manufacturing Standard
Reducing antibiotic resistance and aquatic toxicity risks from antibiotic manufacturing.
New WHO guidance to support manufacturers to reduce AMR risk
The recommendations offered in the guidance is applicable across different areas of manufacturing, from active pharmaceutical ingredients (APIs), through to formulation and packaging.
UK’s NHS to require companies to meet responsible antibiotic manufacturing standard
The United Kingdom’s National Health Service (NHS) announced yesterday that pharmaceutical companies applying for a contract through its antibiotic subscription model will have to prove they are meeting responsible antibiotic manufacturing standards. The first-of-its kind NHS Antimicrobial Product Subscription Model pays companies a fixed annual fee for antibiotics based on their value to the NHS […]
NHS requires compliance with BSI Kitemark™ to promote responsible antibiotic manufacturing
Suppliers will need to certify to BSI Kitemark for Minimized Risk of Antimicrobial Resistance (AMR) 12 August 2024 – Pharmaceutical companies bidding for the newly launched NHS Antimicrobial Product subscription model will be required to demonstrate the steps they are taking to promote responsible antibiotic manufacturing and minimize the risk of antimicrobial resistance by […]
Site in India Receives Responsible Antibiotic Manufacturing Certification
Pharmaceutical company Viatris announced today that its manufacturing site in India has received Minimized Risk of Antimicrobial Resistance (AMR) certification.
Viatris Receives receives Global Minimised Risk of Antimicrobial Resistance Certification
The standard was facilitated by BSI for the AMR Industry Alliance, an organization made up of over 100 companies and associations from across the life-sciences industry with the shared goal of providing sustainable solutions to curb AMR. The certification is designed to encourage drug manufacturers and those in the supply chain to prioritise the sustainable […]
AMR Industry Alliance Contributions to Responsible Antibiotic Manufacturing
The report is based on independent, quality assured research conducted by RAND Europe and funded by the AMR Industry Alliance. Please note the supporting annexes accompanying our research report will be made available at a later date. The annexes consist of two parts: the methods annex, which encompasses the survey questions, and the data/technical annex, which includes […]